HealthMore in Health→
European drug panel backs four new medicines and a new form of Sanofi’s Sarclisa
Key Takeaways
- CHMP recommended four new drugs and a subcutaneous form of Sanofi’s Sarclisa.
- The decision is an important scientific milestone ahead of final European Commission action.
- The Sarclisa update highlights how new formulations can become meaningful regulatory and commercial events.
DE
DT Editorial Team··via endpoints.news